Allergan Aesthetics Announces Positive Topline Results from Second Phase 3 Study of OnabotulinumtoxinA (BOTOX® Cosmetic) for the Treatment of Platysma Prominence – Yahoo Finance

By
Esthetic Advisor
-
0
8
Dermal Fillers Market Size & Share to Surpass $7.9 Billion by 2028 ... - GlobeNewswire



Allergan Aesthetics Announces Positive Topline Results from Second Phase 3 Study of OnabotulinumtoxinA (BOTOX® Cosmetic) for the Treatment of Platysma Prominence  Yahoo Finance



Source link

RELATED ARTICLESMORE FROM AUTHOR